Short Analysis
July 2019

State Efforts to Rein in High Drug Prices in the 2019 Session

This summary outlines significant policies that advanced in 2019 addressing prescription drug prices in states all over the country. Advocates and lawmakers can gain a sense of what has been made possible this legislative session, and gain insight into what could come next to tackle high drug prices. 

 

Short Analysis
July 2019

Health and Health Care in 2019 Legislative Sessions: States Step Up on Public Options, Coverage, Drug Pricing, and More

State lawmakers focused on health care coverage as well as prescription drug and other health costs in a year that also saw Medicaid programs and reproductive health threatened by state and federal policymakers. Families USA’s annual review of state legislative activity found bold new ideas on public options, coverage enrollment, and consumer issues including drug pricing and surprise billing emerging in the statehouses.
July 1, 2019

Maryland’s Path to a Prescription Drug Affordability Board

The drug pricing system in this country is broken. Lifesaving medicines are frequently priced out of reach, resulting in nearly one third of Americans reporting that they have not taken their medication as prescribed due to cost. Despite an overwhelming need and broad public support, very little substantive action has been taken on the federal level. With prescription drug prices continuing to rise, many Americans are left asking, “Will anything be done?” Statehouses across the nation may hold the answer to their question.

Webinar
November 2018

Webinar: State Options to Rein in High Drug Prices

High prescription drug prices hurt families and consumers by adding financial stress to devastating illness.  

States have led the way to take action against high and rising drug prices, and with the help of advocates this action can continue and grow in 2019.  
On this webinar, we explore options and approaches to state drug pricing policy, including a special focus on how states can build upon the success of price transparency laws to provide meaningful information that spurs broader changes.  

Featured speakers:  

Report
August 2018

2018 State Legislation on High and Rising Drug Prices

2018 has been a year of opportunity when it comes to state legislation to address the high and rising prices of prescription drugs. Families USA has identified some of the 2018 state legislative sessions’ biggest victories on the issue of prescription drug costs, along with significant legislation considered in the 2018 session that may be on the agenda again in 2019.

Comment
July 2018

41 Consumer and Patient Groups Urge the Trump Administration to Take Real Action on Prescription Drugs

Families USA, Public Citizen, and 39 other national and state-based organizations including the Services Employees International Union, the National Partnership for Women and Families, the AFL-CIO, AFSCME, and NETWORK Lobby for Catholic Social Justice submitted a comment letter in response to the Request for Information (RFI) from the Trump Administration regarding HHS’ Blueprint on Prescription Drug Costs.  

Pages

Subscribe to Prescription Drugs